CMS Life Sciences Vital Signs, Winter 2023


2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed of.

In the UK, beginning in January 2024, the UK will roll out a new International Recognition Procedure for medicines approved in trusted jurisdictions. There are also new public procurement rules on the horizon as the Procurement Bill has been progressing through the Houses of Parliament, with the aim to make the UK’s public procurement regime more efficient and transparent.

In Europe, the Unified Patent Court, which was opened in June 2023, has seen its first Infringement and revocation actions, and the first pan-European preliminary injunction was granted recently. In the regulatory sphere, a political agreement has been reached on the new Data Act, which will contain new rules on who can use and access data generated in the EU across all economic sectors.

If you would like to discuss these or any other developments, please get in touch. We would be delighted to talk about your interests and concerns.

Publication co-authored by Sholto Dugdale, Trainee Solicitor at CMS.


Click here to read the full publication.